Trademark search for:

AMBLYOTAB

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2022-06-02 — Application filed
2022-06-06 — Application filed
2022-06-10 — Application filed
2022-11-07 — Assigned to examiner
2022-11-16 — Approved for pub - principal register
2022-11-30 — Notification of notice of publication e-mailed
2022-12-20 — Published for opposition
2022-12-20 — Official gazette publication confirmation e-mailed
2023-02-14 — Noa e-mailed - sou required from applicant
2023-08-04 — Sou teas extension received
2023-08-04 — Sou extension 1 filed
2023-08-04 — Sou extension 1 granted
2023-08-08 — Notice of approval of extension request e-mailed
2024-02-12 — Sou teas extension received
2024-02-12 — Sou extension 2 filed
2024-02-12 — Sou extension 2 granted
2024-02-13 — Notice of approval of extension request e-mailed
2024-09-16 — Application abandoned
2024-09-16 — Application abandoned
2024-09-16 — Final status recorded

Owner Information

Novartis AG
Basel CH

Correspondent

Maury M. Tepper, III TEPPER & EYSTER, PLLC
3724 BENSON DR
RALEIGH, NC 27609-7321
United States

Filing Details

Filing Date:
2022-06-02

Status Date:
2024-09-16

Category:
Electronics & Software

Filing Year:
2018

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.